Roche

Pharmacyclics: As Imbruvica Commercialization Begins, Sell-Off Creates Opportunity
Seeking Alpha
Fri, 01/3/14 - 11:56 am
Pharmacyclics
Imbruvica
JNJ
Roche
Celgene
Gilead Sciences
mantle cell lymphoma
Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race
Seeking Alpha
Thu, 01/2/14 - 09:35 am
Bristol-Myers Squibb
Roche
brain cancer
CytRx
Celldex Therapeutics
ImmunoCellular Therapeutics
Northwest Biotherapeutics
glioblastoma multiforme
nivolumab
Yervoy
Grading Pharma In 2013: 16 Drug Companies Ranked
Forbes
Tue, 12/31/13 - 10:17 am
Bristol-Myers Squibb
Celgene
Gilead Sciences
Biogen Idec
AbbVie
Roche
JNJ
GSK
Amgen
Novo Nordisk
Pfizer
Novartis
Merck
Sanofi
AstraZeneca
Eli Lilly
Keep an Eye on These 3 Revolutionary Cancer Treatments in 2014
Motley Fool
Fri, 12/27/13 - 01:08 pm
cancer
Roche
Infinity Pharmaceuticals
Inovio
Immunogen
Gilead Sciences
immunotherapy
antibody-drug conjugate
Roche: Some Companies Rebuild, This One Reloads
Motley Fool
Fri, 12/27/13 - 12:18 pm
Roche
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014
Seeking Alpha
Fri, 12/20/13 - 11:49 am
Inovio
Pharma CEOs
PDL-1
immunotherapy
Joseph Kim
Bristol-Myers Squibb
Roche
Dendreon
GSK
ImmunoCellular Therapeutics
Merck
Northwest Biotherapeutics
Roche Share Discount Widens on Bet Novartis to Sell Stake
Bloomberg
Tue, 12/17/13 - 08:56 am
Roche
Novartis
Why did Roche kill off its Alzheimer's program for the BACE inhibitor RG7129?
Fierce Biotech
Fri, 12/13/13 - 10:51 am
Roche
BACE inhibitors
Alzheimer's disease
RG7129
Avastin Misses Mark Again in Breast Cancer
MedPage Today
Thu, 12/12/13 - 11:15 am
Avastin
Roche
HER-2 postive breast cancer
Roche in deal worth up to $600 mln for Prothena Parkinson's drug
Yahoo/Reuters
Thu, 12/12/13 - 11:13 am
Roche
Prothena
Parkinson's Disease
PRX-022
J&J, Roche, Novartis tout key cancer-drug data at ASH
Fierce Pharma
Mon, 12/9/13 - 10:12 am
JNJ
Roche
Novartis
Imbruvica
Tasigna
CLL
Gazyva
New Leukemia Drugs Bring Chemotherapy-Free Treatment Potential
Bloomberg
Mon, 12/9/13 - 08:38 am
Gilead Sciences
Roche
Pharmacyclics
CLL
chronic lymphocytic leukemia
Breast Cancer Drug Data Boosts Puma Biotechnology
Investors.com
Thu, 12/5/13 - 12:01 pm
Puma Biotechnology
breast cancer
neratinib
Taxol
Bristol-Myers Squibb
Roche
Herceptin
Ditching Big Drugmakers for Biotech Brings Leukemia Boon
Bloomberg
Thu, 12/5/13 - 08:26 am
chronic lymphocytic leukemia
Gilead
Pharmacyclics
CLL
Roche
How The Global Pharma Industry Will Shape Up In The Next 5 Years?
Seeking Alpha
Wed, 12/4/13 - 11:38 am
Bristol-Myers Squibb
GSK
JNJ
Ophthotech
Novartis
Regeneron
Roche
Sanofi
Roche teams with Molecular Partners on armed proteins in $1B-plus deal
Fierce Biotech
Wed, 12/4/13 - 10:18 am
Roche
Molecular Partners
DARPin
PSivida: Undervalued Ophthalmology Small-Cap Investment With Upcoming Catalyst
Seeking Alpha
Tue, 12/3/13 - 11:04 am
pSivida
ophthalmology
GSK
Novartis
Pfizer
Regeneron
Roche
Sanofi
Iluvien
Durasert
Medidur
Opportunities in Lung Cancer Therapies
Motley Fool
Sun, 11/24/13 - 12:30 pm
lung cancer
non-small cell lung cancer
Avastin
Genentech
Roche
Tarceva
AstraZeneca
Iressa
Alimta
selumetinib
Array Biopharma
CO-1686
Clovis Oncology
AP26113
Ariad Pharmaceuticals
The Race For A Cure For Cancer
Seeking Alpha
Thu, 11/21/13 - 12:09 pm
cancer
Merck
Bristol-Myers Squibb
Roche
Peregrine Pharmaceuticals
EU backs Roche’s Kadycla in breast cancer
PM Live
Wed, 11/20/13 - 08:33 am
Europe
Roche
Kadcyla
breast cancer

Pages